GlassScriptPhysician profile
Russell T Phelps
NPI 1356337422
$31,445.12
in general payments reported to CMS, 2019-2025
13 companies · $9,382 in 2025
The $9,382 reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,236 · 2020: $4,652 · 2021: $175 · 2022: $1,614 · 2023: $309 · 2024: $10K · 2025: $9,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $19K · Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $19,108.48 |
| Food and Beverage | $658.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20,766.62 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $9,684.51 | 2019-2021 | |
| Abbvie INC. | $574.76 | 2019-2023 | |
| Mylan Pharmaceuticals INC. | $94.37 | 2020-2022 | |
| Sage Therapeutics, LLC | $84.86 | 2024 | |
| Pfizer INC. | $82.11 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $47.01 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $34.97 | 2024 | |
| Daiichi Sankyo INC. | $16.70 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.11 | 2024 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $15.66 | 2021 | |
| Hologic Sales and Service, LLC | $14.60 | 2019 | |
| Avion Pharmaceuticals | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Phelps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.